查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414299

2024 年肥厚性疤痕和瘢痕疙瘩治疗全球市场报告

Hypertrophic And Keloid Scar Treatment Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肥厚性疤痕和瘢痕疙瘩疙瘩治疗的市场规模迅速扩大。将从2023年的69.1亿美元增加到2024年的76.7亿美元，复合年增长率为11.0%。过去一段时间的扩张是由于肥厚性疤痕和瘢痕疙瘩疙瘩发病率增加、疤痕评估技术的进步、局部治疗、手术和侵入性手术的普及以及患者对疤痕改善的需求增加等因素造成的。到

肥厚性疤痕和瘢痕疙瘩疙瘩治疗市场规模预计在未来几年将强劲成长。 2028年，将以9.8%的复合年增长率成长至111.4亿美元。预测期内的预期增长可归因于微创干预措施的出现、疤痕矫正技术的进步、对联合治疗日益增长的兴趣、意识和早期疗育的提高、全球美容趋势等。预测期内预期的主要趋势包括用于疤痕治疗的注射疗法的出现、使用联合治疗产生协同效应、以患者为中心的疤痕管理方法、疤痕评估技术的发展、增生性疤痕和疤痕治疗等，其中包括使用远端医疗进行后续治疗。瘢痕疙瘩疙瘩治疗领域的检查和咨询。

由于道路事故和烧伤病例的增加，肥厚性疤痕和瘢痕疙瘩疙瘩治疗市场预计将成长。涉及至少一辆车和一个人的交通事故需要注意并进行有效治疗，以消除由此造成的疤痕。肥厚性疤痕和疤痕瘢痕疙瘩治疗在降低疤痕高度和硬度方面发挥重要作用，有助于市场扩张。例如，根据美国公路交通安全管理局2022年8月的统计数据，2022年1月至3月汽车交通死亡人数较2021年同期成长近7%，呈上升趋势，凸显了疤痕治疗的必要性。此类情况。

随着整容手术变得越来越普及，肥厚性疤痕和瘢痕疙瘩治疗市场也有望扩大。整容手术旨在透过非侵入性或微创美容疗程来改善外观，通常会结合疤痕治疗以改善美观效果。肥厚性疤痕和瘢痕疙瘩疙瘩治疗市场正受益于这一趋势，有助于使外观更光滑、更美丽。美容协会报告称，2021 年美国整形手术数量将大幅增加 54%，显示对美容介入的需求不断增长。

2023年，北美是肥厚性疤痕和瘢痕疙瘩治疗市场最大的地区。在肥厚性疤痕和瘢痕疙瘩治疗的全球市场报告中，亚太地区预计将成为预测期内成长最快的地区。肥厚性疤痕和瘢痕疙瘩治疗市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球肥厚性疤痕和瘢痕疙瘩治疗市场，依治疗、表现和预测细分，2018-2023、2023-2028、2033
  • 冷冻疗法
  • 手术切除
  • 加压绷带
  • 病灶内5-Fluorouracil
  • 表面X射线
  • 病灶内注射皮质类固醇
  • 其他的
  • 全球肥厚性疤痕和瘢痕疙瘩治疗市场，按产品、性能和预测细分，2018-2023、2023-2028、2033
  • 外部产品
  • 雷射产品
  • 注射
  • 其他的
  • 全球肥厚性疤痕和瘢痕疙瘩治疗市场，依疤痕细分，实际和预测，2018-2023、2023-2028、2033
  • 增生性疤痕
  • 疤痕瘢痕疙瘩
  • 全球肥厚性疤痕和瘢痕疙瘩治疗市场，依最终用途、表现和预测细分，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 其他的

第 7 章 区域与国家分析

  • 全球肥厚性疤痕和瘢痕疙瘩治疗市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球肥厚性疤痕和瘢痕疙瘩治疗市场，依国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 增生性疤痕和瘢痕疙瘩治疗市场的竞争形势
  • 肥厚性疤痕和瘢痕疙瘩治疗市场公司概况
    • Smith &Nephew plc
    • Merz Pharmaceutical LLC
    • Lumenis Ltd.
    • Enaltus LLC
    • Sonoma Pharmaceuticals Inc.

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r11809

“Hypertrophic And Keloid Scar Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hypertrophic and keloid scar treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hypertrophic and keloid scar treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hypertrophic and keloid scar treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
  • 2) By Products: Topical Products; Laser Products; Injectables; Other Products
  • 3) By Scar: Hypertrophic Scars; Keloid Scars
  • 4) By End-Use: Hospitals; Clinics; Other End-Users
  • Companies Mentioned: Smith & Nephew plc; Merz Pharmaceutical LLC; Lumenis Ltd.; Enaltus LLC; Sonoma Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hypertrophic and keloid scar treatment involves addressing scars that either remain within the boundaries of the original wound (hypertrophic) or extend beyond those boundaries and do not regress (keloids). Hypertrophic scars are contained within the area of the initial injury, while keloids spread outside the boundaries of the initial damage.

The main treatments for hypertrophic and keloid scars include cryotherapy, surgical excision, pressure dressings, intralesional 5-fluorouracil, superficial X-ray, intralesional corticosteroid injection, and others. Cryotherapy is a medical procedure that uses extremely cold liquid or a cryoprobe to freeze and destroy abnormal tissue. It is employed to destroy the core of keloid scars while preserving surface-level cells and tissues. Various products, including topical products, laser products, injectables, and others, are used during treatment. The end-users of hypertrophic and keloid scar treatment include hospitals, clinics, and other healthcare facilities.

The hypertrophic and keloid scar treatment market research report is one of a series of new reports from The Business Research Company that provides hypertrophic and keloid scar treatment market statistics, including hypertrophic and keloid scar treatment industry global market size, regional shares, competitors with a hypertrophic and keloid scar treatment market share, detailed hypertrophic and keloid scar treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hypertrophic and keloid scar treatment industry. This hypertrophic and keloid scar treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hypertrophic and keloid scar treatment market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The expansion observed during the historical period can be attributed to factors such as the increased incidence of hypertrophic and keloid scars, advancements in scar assessment techniques, widespread adoption of topical treatments, surgical and invasive procedures, and growing patient demand for scar improvement.

The hypertrophic and keloid scar treatment market size is expected to see strong growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, a growing interest in combination therapies, increasing awareness and early intervention, and global aesthetic trends. Major trends expected in the forecast period include the emergence of injectable therapies for scar treatment, the use of combination therapies for synergistic effects, patient-centric approaches to scar management, the development of scar assessment technologies, and the utilization of telemedicine for follow-up and consultations in the field of hypertrophic and keloid scar treatment.

The hypertrophic and keloid scar treatment market is anticipated to witness growth due to an increase in the number of road accidents and burn cases. Road accidents involving at least one vehicle and individuals necessitate attention and effective treatment to address resulting scars. Hypertrophic and keloid scar treatments play a crucial role in lowering the height and tightness of scars, contributing to the market's expansion. For instance, statistics from the National Highway Traffic Safety Administration in August 2022 revealed a nearly 7% increase in motor vehicle traffic accident fatalities during the first three months of 2022 compared to the same period in 2021, highlighting the need for scar treatments in such cases.

The market for hypertrophic and keloid scar treatment is also expected to grow with the increasing prevalence of aesthetic procedures. Aesthetic procedures, which aim to enhance appearance through non-invasive or minimally invasive cosmetic treatments, often incorporate scar treatment to improve the outcome aesthetically. The hypertrophic and keloid scar treatment market benefits from this trend, contributing to a smoother and more pleasing appearance. The Aesthetic Society reported a significant 54% rise in US plastic surgical procedures in 2021, indicating a growing demand for aesthetic interventions.

Leading companies in the hypertrophic and keloid scar treatment market are strategically focusing on the development of clinically proven solutions, particularly those based on silicone, such as medical-grade silicone strips. These therapeutic products made from high-quality silicone are formulated to promote scar healing and reduction, offering an effective solution for various scar types. An example is Scar Erase, a UK-based company, which launched clinically tested silicone strips designed for scar healing and reduction, catering to hypertrophic, keloid, post-surgery, and stretch mark scars.

Major players in the market are also investing in advanced dermatological lines that leverage innovative technologies such as Microcyn technology. This technology accelerates wound healing, combats infections, and alleviates symptoms, providing clinically proven solutions. Sonoma Pharmaceuticals, a US-based pharmaceutical company, introduced a line of office dispensed products, including Regenacyn Plus, which is clinically proven to enhance the appearance of keloid and hypertrophic scars, offering relief from itch and pain while reducing infection risk.

In July 2022, Sinclair Pharma, a UK-based aesthetics company, completed the acquisition of Viora Ltd. The financial details of the acquisition remain undisclosed. This strategic move is expected to grant Sinclair access to Viora's portfolio of non-invasive and minimally invasive aesthetic devices. Additionally, the acquisition is anticipated to facilitate Sinclair's entry into the US market on a commercial scale. Viora Ltd., based in the US, specializes in providing medical aesthetic devices and solutions, including offerings related to scar and stretch mark revision, acne clearance, and various other aesthetic treatments.

Major companies operating in the hypertrophic and keloid scar treatment market report are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Mylan N.V., Stratpharma AG, Revitol Corporation Inc., Quantum Health, Scarfade, Biodermis, Renovo Group plc, Mederma, Silagen

North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hypertrophic and keloid scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hypertrophic and keloid scar treatment market consist of revenues earned by entities by providing occlusive dressings, compression therapy, intralesional corticosteroid injections, cryosurgery, excision, radiation therapy, laser therapy, interferon (IFN) therapy, doxorubicin, bleomycin, and verapamil. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypertrophic and keloid scar treatment market also includes sales of skin camouflage, silicon gels, and skin needling. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hypertrophic And Keloid Scar Market Characteristics

3. Hypertrophic And Keloid Scar Market Trends And Strategies

4. Hypertrophic And Keloid Scar Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Hypertrophic And Keloid Scar Market Size and Growth

  • 5.1. Global Hypertrophic And Keloid Scar Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hypertrophic And Keloid Scar Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hypertrophic And Keloid Scar Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hypertrophic And Keloid Scar Market Segmentation

  • 6.1. Global Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cryotherapy
  • Surgical Excision
  • Pressure Dressings
  • Intralesional 5-Fluorouracil
  • Superficial X-Ray
  • Intralesional Corticosteroid Injection
  • Other Treatments
  • 6.2. Global Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Topical Products
  • Laser Products
  • Injectables
  • Other Products
  • 6.3. Global Hypertrophic And Keloid Scar Market, Segmentation By Scar, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hypertrophic Scars
  • Keloid Scars
  • 6.4. Global Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Other End-Users

7. Hypertrophic And Keloid Scar Market Regional And Country Analysis

  • 7.1. Global Hypertrophic And Keloid Scar Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hypertrophic And Keloid Scar Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hypertrophic And Keloid Scar Market

  • 8.1. Asia-Pacific Hypertrophic And Keloid Scar Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hypertrophic And Keloid Scar Market

  • 9.1. China Hypertrophic And Keloid Scar Market Overview
  • 9.2. China Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hypertrophic And Keloid Scar Market

  • 10.1. India Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hypertrophic And Keloid Scar Market

  • 11.1. Japan Hypertrophic And Keloid Scar Market Overview
  • 11.2. Japan Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hypertrophic And Keloid Scar Market

  • 12.1. Australia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hypertrophic And Keloid Scar Market

  • 13.1. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hypertrophic And Keloid Scar Market

  • 14.1. South Korea Hypertrophic And Keloid Scar Market Overview
  • 14.2. South Korea Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hypertrophic And Keloid Scar Market

  • 15.1. Western Europe Hypertrophic And Keloid Scar Market Overview
  • 15.2. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hypertrophic And Keloid Scar Market

  • 16.1. UK Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hypertrophic And Keloid Scar Market

  • 17.1. Germany Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hypertrophic And Keloid Scar Market

  • 18.1. France Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hypertrophic And Keloid Scar Market

  • 19.1. Italy Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hypertrophic And Keloid Scar Market

  • 20.1. Spain Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hypertrophic And Keloid Scar Market

  • 21.1. Eastern Europe Hypertrophic And Keloid Scar Market Overview
  • 21.2. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hypertrophic And Keloid Scar Market

  • 22.1. Russia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hypertrophic And Keloid Scar Market

  • 23.1. North America Hypertrophic And Keloid Scar Market Overview
  • 23.2. North America Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hypertrophic And Keloid Scar Market

  • 24.1. USA Hypertrophic And Keloid Scar Market Overview
  • 24.2. USA Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hypertrophic And Keloid Scar Market

  • 25.1. Canada Hypertrophic And Keloid Scar Market Overview
  • 25.2. Canada Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hypertrophic And Keloid Scar Market

  • 26.1. South America Hypertrophic And Keloid Scar Market Overview
  • 26.2. South America Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hypertrophic And Keloid Scar Market

  • 27.1. Brazil Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hypertrophic And Keloid Scar Market

  • 28.1. Middle East Hypertrophic And Keloid Scar Market Overview
  • 28.2. Middle East Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hypertrophic And Keloid Scar Market

  • 29.1. Africa Hypertrophic And Keloid Scar Market Overview
  • 29.2. Africa Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hypertrophic And Keloid Scar Market Competitive Landscape And Company Profiles

  • 30.1. Hypertrophic And Keloid Scar Market Competitive Landscape
  • 30.2. Hypertrophic And Keloid Scar Market Company Profiles
    • 30.2.1. Smith & Nephew plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merz Pharmaceutical LLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Lumenis Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Enaltus LLC
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sonoma Pharmaceuticals Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Hypertrophic And Keloid Scar Market Competitive Benchmarking

32. Global Hypertrophic And Keloid Scar Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hypertrophic And Keloid Scar Market

34. Hypertrophic And Keloid Scar Market Future Outlook and Potential Analysis

  • 34.1 Hypertrophic And Keloid Scar Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Hypertrophic And Keloid Scar Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Hypertrophic And Keloid Scar Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer